COM:CUEHEALTH
Cue
- Stock
Last Close
0.06
05/06 20:00
Market Cap
6.90M
Beta: -
Volume Today
50.91M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 18.76M - | 62.62M 233.85% | 85.30M 36.23% | 48.12M 43.58% | ||
average payables | 12.51M - | 30.53M 144.07% | 22.18M 27.35% | 7.43M 66.51% | ||
average receivables | 2.18M - | 54.38M 2,389.86% | 61.67M 13.41% | 10.20M 83.46% | ||
book value per share | -0.45 - | -0.79 74.41% | 13.38 1,789.67% | 3.89 70.90% | 1.64 57.97% | |
capex per share | -0.02 - | -0.61 2,553.58% | -2.19 258.97% | -0.43 80.57% | -0.13 69.59% | |
capex to depreciation | -0.81 - | -12.44 1,443.07% | -3.56 71.39% | -1.40 60.60% | -0.35 74.92% | |
capex to operating cash flow | 0.23 - | -0.84 472.20% | 12.25 1,551.99% | 0.56 95.40% | 0.14 74.49% | |
capex to revenue | -0.44 - | -3.40 666.03% | -0.19 94.50% | -0.13 30.36% | -0.28 114.09% | |
cash per share | 0.11 - | 0.95 748.53% | 7.76 717.27% | 1.63 78.97% | 0.53 67.25% | |
days of inventory on hand | 899.43 - | 116.66 87.03% | 90.94 22.05% | 40.32 55.66% | ||
days payables outstanding | 582.18 - | 49.11 91.56% | 7.91 83.90% | 22.13 179.79% | ||
days sales outstanding | 11.02 - | 66.28 501.60% | 61.76 6.82% | 14.16 77.08% | 8.50 39.95% | |
debt to assets | 0.26 - | 0.06 76.37% | 0.06 1.08% | 0.08 25.09% | 0.14 78.19% | |
debt to equity | -0.12 - | -0.20 56.66% | 0.08 143.10% | 0.10 13.31% | 0.19 100.81% | |
dividend yield | ||||||
earnings yield | -0.01 - | -0.02 129.66% | 0.12 745.78% | -0.63 619.05% | -15.03 2,273.72% | |
enterprise value | 2.55B - | 2.46B 3.71% | 357.89M 85.45% | 119.88M 66.50% | -8.91M 107.43% | |
enterprise value over ebitda | -151.96 - | -63.38 58.29% | 2.73 104.31% | -0.60 121.80% | 0.04 106.22% | |
ev to operating cash flow | -196.50 - | 26.54 113.51% | -37.88 242.72% | -1.07 97.17% | 0.06 106.03% | |
ev to sales | 385.40 - | 107.13 72.20% | 0.58 99.46% | 0.25 57.18% | -0.13 150.64% | |
free cash flow per share | -0.12 - | 0.11 191.00% | -2.37 2,191.62% | -1.18 50.13% | -1.03 12.77% | |
free cash flow yield | -0.01 - | 0.01 191.00% | -0.18 3,219.49% | -0.57 223.08% | -6.34 1,011.16% | |
graham net net | -0.55 - | -2.14 288.47% | 5.66 364.14% | 1.21 78.70% | 0.00 99.78% | |
graham number | 1.30 - | 2.59 100.14% | 22.20 755.35% | 10.72 51.71% | 9.49 11.50% | |
income quality | 0.63 - | -1.96 410.25% | -0.11 94.41% | 0.58 627.47% | 0.37 36.02% | |
intangibles to total assets | 0 - | 0.01 Infinity% | 0.01 26.69% | 0.02 197.51% | 0.06 138.07% | |
interest coverage | -136.63 - | -45.86 66.43% | 10.03 121.88% | -315.71 3,246.44% | -256.01 18.91% | |
interest debt per share | 0.06 - | 0.16 180.91% | 1.31 708.10% | 0.38 71.36% | 0.32 14.56% | |
inventory turnover | 0.41 - | 3.13 670.98% | 4.01 28.29% | 9.05 125.54% | ||
invested capital | -0.12 - | -0.20 56.66% | 0.08 143.10% | 0.10 13.31% | 0.19 100.81% | |
market cap | 2.56B - | 2.56B 0% | 708.26M 72.34% | 306.41M 56.74% | 24.84M 91.89% | |
net current asset value | -70.00M - | -234.03M 234.35% | 436.71M 286.61% | 253.07M 42.05% | 20.83M 91.77% | |
net debt to ebitda | 0.42 - | 2.62 522.80% | -2.68 202.02% | 0.93 134.66% | 0.14 84.86% | |
net income per share | -0.16 - | -0.38 129.66% | 1.64 533.00% | -1.31 180.12% | -2.44 86.34% | |
operating cash flow per share | -0.10 - | 0.72 812.95% | -0.18 124.72% | -0.76 322.61% | -0.90 19.23% | |
payables turnover | 0.63 - | 7.43 1,085.46% | 46.15 520.94% | 16.49 64.26% | ||
receivables turnover | 33.13 - | 5.51 83.38% | 5.91 7.32% | 25.78 336.29% | 42.94 66.54% | |
research and ddevelopement to revenue | 3.23 - | 1.24 61.59% | 0.07 94.42% | 0.35 411.79% | 2.12 498.75% | |
return on tangible assets | -0.77 - | -0.15 80.01% | 0.09 160.21% | -0.29 408.94% | -1.17 307.40% | |
revenue per share | 0.05 - | 0.18 246.41% | 11.70 6,428.27% | 3.27 72.09% | 0.46 85.79% | |
roe | 0.36 - | 0.48 31.68% | 0.12 74.37% | -0.34 375.29% | -1.49 343.34% | |
roic | 0.42 - | 0.69 61.45% | 0.09 87.40% | -0.28 426.80% | -0.88 213.15% | |
sales general and administrative to revenue | 0.89 - | 1.04 17.11% | 0.13 87.62% | 0.20 55.59% | 0.81 302.58% | |
shareholders equity per share | -0.45 - | -0.79 74.41% | 13.38 1,789.67% | 3.89 70.90% | 1.64 57.97% | |
stock based compensation to revenue | 0.05 - | 0.14 171.75% | 0.07 48.09% | 0.13 85.88% | 0.69 416.65% | |
tangible asset value | -58.14M - | -103.44M 77.91% | 699.08M 775.84% | 559.63M 19.95% | 230.61M 58.79% | |
tangible book value per share | -0.45 - | -0.81 77.91% | 13.24 1,738.40% | 3.78 71.44% | 1.51 60.10% | |
working capital | 10.75M - | 27.80M 158.55% | 503.09M 1,709.53% | 299.96M 40.38% | 66.90M 77.70% |
All numbers in USD (except ratios and percentages)